MontereyBud
5 years ago
I've seen the Modesto facility with my own eyes, and I DO believe in TransCanna.
Purchased from Chad Swan in early 2019, the Modesto facility was built by Swan. Mr. Swan has specialized in building USDA food grade facilities throughout the United States for the past several years.
No "Option"
According to ValueSpectrum, "In Q2 the Company acquired the Modesto facility for US$15 million- a 196,000 sq ft. former food processing facility that had recently undergone a US$8M conversion to a vertically integrated cannabis operation." And according to VS, "the Modesto facility is ready to scale and is designed for a nursery, cultivation, manufacturing, kitchen, bottling, and transportation division."
See video
SoCal facility
As for TCAN's SoCal facility, the company has never stated that it was anything other than a sublease, despite any implication to the contrary. "TransCanna Completes Sub-Lease Of 10,000 Square Foot Facility In Adelanto, CA"
Shape of LDS
You also noted that when Jim Pakulis stepped down as CEO of Lifestyle Delivery Systems Inc. in 2018, he "left it in terrible shape." But is seems striking that despite the fact that LDS has only one product (CannaStrips), Pakulis managed to help create a company that has a current market cap of $28.4 million.
While I can only guess that Jim knows Brad, I seriously doubt either would do anything that might intentionally jeopardize their company's respective stock value.
Stealing Shares?
In a now dead deal, TransCanna Holdings Inc. announced on July 1, 2019, that it planed to acquire Lifestyle Delivery Systems Inc. (CSE:LDS) in an all-stock deal valued at $51.7M, or $0.43 per share, based on an exchange ratio of one TransCanna share for 10 Lifestyle Delivery Systems shares.
According to SmallCap Power, "the all-stock transaction" would have represented "a 16.6% premium over LDS’s closing price of $0.37 on Friday, June 28, 2019."
IMO, as is true with any stock in the cannabis sector, investors need to have a long-term plan. While the sales of marijuana products are expected to soar in the next few years, there will be setbacks along the way.
Good luck with LDS...
MontereyBud
5 years ago
Due Diligence will prove TCAN Strong!
Here are the five main takeaways from the company's conference call on July 3, 2019.
1) Acquire physical assets and be poised to scale;
2) Find and retain top-tier management;
3) Identify quality brands for purchase;
4) Create internal distribution system;
5) Create and implement proprietary software platform;
Physical Assets:
- In Q2 the Company acquired the Modesto facility for US$15 million - a 196,000 sq ft. former food processing facility that had recently undergone a US$8M conversion to a vertically integrated cannabis operation. The Modesto facility is ready to scale and is designed for a nursery, cultivation, manufacturing, kitchen, bottling, and transportation division. Licensing at the facility remains pending.
Top-Tier Management:
- Chad Swan, an advisor to the Company and the vendor of the facility, has been a significant contributor to the ongoing success of TransCanna and continues to oversee the buildout of the Company's cannabis facilities. In addition, his relationships with the city and county officials have been invaluable as we continue to move forward with our licensing processes.
- Alan Applonie joined the Company this past month as general manager. Alan brings with him over 30 years' experience growing national brands and managing all aspects of supply chain and operations for CPG products. Alan's most recent position was for a multi-billion-dollar enterprise in which his division oversaw 1,500 employees and regularly produced greater than $300 million in annual revenues. Alan currently oversees all activities at the Modesto facility.
Management Team Through Proposed Acquisitions:
- Each of the principals at Soldaze, Lyfted and Goodfellas have significant industry experience and will bring that experience to TransCanna subject to the closing of each transaction.
Acquiring and Creating Brands:
- Having reviewed over 100 branded products in California, TransCanna has been extremely selective in its proposed acquisition vetting process. The Company's three mandatory acquisition criteria include SKU velocity, strong management, and products that differentiate themselves in the marketplace. TransCanna will also build its own brands over time, but is focused on the integration of its proposed acquisitions.
Closing Transactions:
- The audit of Goodfellas Group was just recently completed, allowing for the completion of definitive agreements. The Company anticipates this transaction will close in the next ten days. The Company anticipates closing the proposed acquisitions of SolDaze and Biovelle (a CBD based cream) and Lyfted Farms within the next sixty days.
Licensing:
- Adelanto - TransCanna received permanent manufacturing and permanent transportation licenses from the city of Adelanto and anticipates receipt of its state licenses later this month. The build out of the facility is approximately 60% complete and hoping to be operational by month's end.
- Modesto - Although the Company's primary property is located in Modesto, it is legislated by the county. The license application process is pending.
Guest speaker Brad Eckenweiler, CEO of Lifestyle Delivery Systems, spoke to the synergies between TransCanna and LDS with regards to manufacturing, transportation, distribution, nursery and genetics coupled with LDS's delivery and dispensary business. The positive alignment of these two organizations should be evident within the next sixty days giving shareholders ample time to make an informed decision about the upcoming proposed acquisition.
"Everything we had hoped to accomplish within the first year of taking TransCanna public, we've fortunately been able to accomplish almost all of it within the first six months," said Jim Pakulis, CEO of TransCanna. "The team has been going at an accelerated pace to complete the first three phases of our strategy: finding physical assets, finding top-tier management and finding the right enterprises to acquire. Now it's closing those acquisitions and getting us to the revenue stage."
Read more
NetworkNewsWire
5 years ago
Acquisitions, Licenses, Research Key in Consistent Cannabis Market Growth
CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business and big money, with much of growth based on acquisitions, agreements and consistent research.
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) is focused on creating a large operation with various licenses and recognized brands, with several key acquisitions, being part of that strategy. Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) is in the process of acquiring PharmaCann, which recently received an extension to complete the development of its cultivation facility in Ohio. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) just entered into a multiyear supply agreement that will help the company provide high-quality products to consumers in anticipation of the derivative market launching in Canada this fall. Tilray Inc. (NASDAQ: TLRY) recently completed its acquisition of Manitoba Harvest, the largest hemp food company. GW Pharmaceuticals Plc (NASDAQ: GWPH) continues its march forward as a leader in cannabinoid prescription medicines sector with its recent announcement of positive, top-line results of a Phase 3 clinical trial of Epidiolex® in the treatment of seizures associated with a rare and severe form of childhood-onset epilepsy.
- Cannabis companies are engaging in multimillion-dollar acquisitions in growing numbers.
- This strategy supports a consolidation of the industry as it moves from scattered creativity to efficient large businesses.
- The trend is built in part on intangible assets, including brands, licenses and research.
To view an infographic of this editorial, click here.
A Very Different Business
The image of the cannabis industry varies significantly depending upon an individual’s point of view. To supporters, the market is a transformative sector aimed at bringing the world together. Detractors call the industry one more vice threatening public morals. For many standing in the middle ground, the sector is a space where hippies and stoners can thrive but not necessarily one that encourages the buzz and dynamism of mainstream business.
In reality, the cannabis sector fits none of these images. The industry is emerging from its early nascent steps into legality to become a significant business sector much like any other, with all the elements of modern capitalism. This growth appears to be reflected in the sector’s recent burst of mergers and acquisitions.
Big-Money Deals
Certainly one of the most eye-catching aspect of mergers and acquisitions in the cannabis sector is the significant amount money involved. Take just two recent examples from a single company: TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8).
In the past few months, the Vancouver-based cannabis company has made announcements on two major deals. First came the acquisition of a 196,000-square-foot vertically integrated cannabis facility for a total purchase price of $15 million. Then came a letter of intent relating to Californian company Lyfted Farms outlining TransCanna’s plans to acquire Lyfted’s business and assets for $5.5 million.
By some standards, these might not seem like significant deals. But when a company is investing $20 million on expansion in the space of a couple of months, stability seems evident. That TransCanna can make these deals is a show not only of the strength of the company but also the strength of the industry.
The financial growth of the legal cannabis industry has been a positive move for everyone from company leaders to their lowest-paid employees. The legalized trade is pulling money out of the black-market economy and allowing those at the top to earn big bucks while also providing employees with a decent wage. Far from weakening the power of legal providers, paying employees properly is leaving them with enough money to go around buying up competitors, as TransCanna is doing.
Success has also brought funds from outside. From private individuals to big alcohol and tobacco companies, investors are pouring money into pot, allowing businesses to expand while keeping their employees happy. There are living wages at the bottom and big money at the top.
Tidying Up the Market
The progression of the legal cannabis industry started with a scattered approach. TransCanna is one of many companies that started in the market with a relatively small presence. Some began as entrepreneurs seeing a new industry within which to operate. Others were experienced cannabis cultivators moving from the illegal to the legal market. Still others were pharmaceutical companies dipping their toes into a new medicine and, from there, into the recreational industry.
As a result, the cannabis industry was initially made up of diverse and disconnected businesses. Now, however, the sector is moving toward a space of consolidation.
This doesn’t mean that the variety created in that early surge is being lost. When larger companies buy up smaller ones, the aim is often to continue supporting and growing the individual brands and styles the smaller companies have created. For example, TransCanna has announced the acquisition of GoodFellas, allowing TransCanna to take control of the Daily Cannabis Goods brand. TransCanna CEO Jim Pakulis has talked not in terms of absorbing the Daily brand into TransCanna’s existing identity but in terms of maintaining Daily and expanding its sales.
The consolidation of multiple brands and businesses into a smaller number reflects a dialectic process that’s common in new business areas. First comes a burst of creativity. With few precedents and no big players dominating the market, entrepreneurs and creatives have free rein. Some of their experiments fail, but the ones that succeed get consumers interested and fill the market with ideas.
While this creates plenty of exciting idea and products, it’s also inefficient. In the phase that follows, bigger companies step in or emerge from among the smaller ones. Consolidation creates efficiency, providing more reliable products for consumers and better value for companies.
The Power of the Immaterial
In the illegal market, product was the main focus for cannabis sellers. In the legal market, the focus is different. When a company relies on the full complement of marketing, intangible assets become important. That’s why GoodFellas is valuable to TransCanna — not just for its cannabis but for the Daily brand attached to it.
And while intangible assets are normally talked about in terms of brand and IP, there’s another sort of asset that gets much less publicity and that the cannabis industry is bringing to investors’ attention: legal licenses.
Licenses of various sorts are important for a wide range of industries, from food production to mining. But they have a particular prominence in the cannabis industry because tight regulation has created a scarcity of licenses. When TransCanna subsidiary TCM Distribution Inc. gained cannabis manufacturing and distribution permits from the City of Adelanto, California, it was an important step in the company’s growth within the state. And when a deal like TransCanna’s acquisition of Lyfted is announced, the target’s cannabis licenses are often mentioned. These licenses are a crucial asset and one that investors are concerned about. Without the licenses, the business can’t function.
The prominence of licenses is a new feature of investment for those going into cannabis. But it could be a feature that helps investors recognize these assets in other companies. Cannabis companies are increasingly about immaterial assets, and immaterial assets are increasingly about licenses as well as IP.
Keeping Profiles High
In such an atmosphere, cannabis companies are working hard on keeping their profiles high while building up their portfolios of products.
Last year Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced the deal to buy PharmaCann. PharmaCann is working to complete its $20-million cultivation center, which must be operational before the acquisition can be completed to comply with Ohio law, which requires a licensee to have operating certification before transferring a license to another owner. The deal will double the number of states where Los Angeles-based MedMen has licenses to operate – expanding the firm’s reach to 12 states with 66 retails stores and 13 cultivation facilities.
The agreement between Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) and MediPharm Labs Corp. will supply Cronos Group with approximately $30 million of high-quality, private-label cannabis concentrate over 18 months and, subject to certain renewal and purchase options, potentially up to $60 million concentrate over 24 months. In addition, Cronos Group and MediPharm Labs have entered into a multiyear tolling agreement, where Cronos Group will supply bulk cannabis to MediPharm Labs’ state-of-the-art extraction facility in Ontario.
With the completion of the acquisition, Manitoba Harvest will operate as a wholly owned subsidiary of Tilray Inc. (NASDAQ: TLRY), leveraging the expertise of Tilray’s global cannabis industry expertise. “Tilray’s acquisition of Manitoba Harvest is a milestone for the cannabis industry,” said Tilray president and CEO Brendan Kennedy. “It builds on the strategic partnerships we have formed with consumer brand industry leaders and demonstrates our track record of disrupting the global pharmaceutical, alcohol, CPG, and functional food and beverage categories. We’re excited to work with Manitoba Harvest to develop and distribute a diverse portfolio of branded hemp-derived CBD food and wellness products in the U.S. and Canada.”
The newest test results from GW Pharmaceuticals Plc (NASDAQ: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, expands the company’s knowledge of Epidiolex and its potential use beyond the current indications. “Data from previous controlled clinical trials of EPIDIOLEX have shown clinically meaningful seizure reductions and consistent safety and tolerability in children and adults with Lennox-Gastaut syndrome and Dravet syndrome,” said Dr. Elizabeth Thiele, the lead investigator of the trial, director of the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and a professor of neurology at Harvard Medical School. “Based on the positive results of this trial in TSC patients, Epidiolex, if approved for this additional indication, may become an important treatment option also in this disease state with significant unmet medical need.”
The cannabis industry is clearly evolving with big money, consolidation and growing intangible assets playing pivotal roles in the growing strength and consistency of the sector.
For more information on TransCanna Holdings, visit TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
6 years ago
Acquisitions Reveal the Steadily Changing Shape of the Cannabis Sector
CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.
TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has taken a similar path with the acquisition of Newstrike. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is building a positive public profile through releasing educational tools. Aphria Inc. (TSX: APHA) (NYSE: APHA) has expanded the hunt for cultivation licenses to Germany. Meanwhile, companies such as Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) keep releasing new products into the market.
- Cannabis companies are increasingly engaging in multimillion-dollar acquisitions.
- These support a consolidation of the industry as it moves from scattered creativity to efficient large businesses.
- The trend built in part on intangible assets, including brands and licenses.
To view an infographic of this editorial, click here.
A Very Different Business
The image of the cannabis industry varies hugely depending upon one’s point of view. To proponents, the market is a radical and transformative sector that’s bringing the world together. For opponents, it is one more vice threatening public morals. For many in the middle ground, it’s a space where hippies and stoners can thrive, though not one that encourages the buzz and dynamism of mainstream business.
In reality, the cannabis sector fits none of these images. The industry is emerging from its early, tentative steps into legality to become a significant business sector much like any other, with all the apparatus of modern capitalism and a focus on intangible assets such as intellectual property. All of this is reflected in the sector’s recent burst of mergers and acquisitions.
Big Money Deals
The most eye-catching aspect of mergers and acquisitions in the cannabis sector is the amount of money that goes into them. Take just two recent examples from a single company, TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8). In the past few months, the Vancouver-based cannabis company has made announcements on two major deals. First came the acquisition of a 196,000-square-foot vertically integrated cannabis facility for a total purchase price of $15 million. Then came a letter of intent relating to Californian company Lyfted Farms outlining TransCanna’s plans to acquire Lyfted’s business and assets for $5.5 million.
By the standards of some businesses, these might not seem like huge deals. But when a company is investing $20 million on expansion in the space of a couple of months, that certainly says something. That TransCanna can make these deals is a show not only of the strength of the company but also the strength of the industry.
The idea that there’s a lot of money in cannabis might not be surprising to anyone who’s seen TV depictions of the drug trade. Dramas such as Narcos show a world of high earners with big stacks of cash. But as sociologists such as Sudhir Venkatesh have shown, the reality for most people working in the illegal drug trade is vastly different. They earn less than minimum wage in jobs that are dangerous and uncertain.
The financial growth of the legal cannabis industry has therefore been a positive move for everyone from company leaders to their lowest-paid employees. The legalized trade is pulling money out of the black-market economy and allowing those at the top to earn big bucks while also providing employees with a decent wage. Far from weakening the power of legal providers, paying employees properly is leaving them with enough money to go around buying up competitors, as TransCanna is doing.
Success has also brought funds from outside. From private individuals to big alcohol and tobacco companies, investors are pouring money into pot, allowing businesses to expand while keeping their employees happy. There are living wages at the bottom and big money at the top.
Tidying Up the Market
The growth of the legal cannabis industry started with a scattershot approach. TransCanna is just one of many companies that have grown into the market from relatively small beginnings. Some began with entrepreneurs seeing a new industry within which to operate. Others were experienced cannabis cultivators moving from the illegal to the legal market. Still others were pharmaceutical companies dipping their toes into a new medicine and, from there, into the recreational industry.
As a result, the cannabis industry is cluttered with diverse and disconnected businesses. But now it’s moving on from this scatter-gun approach to a period of consolidation.
This doesn’t mean that the variety created in that early surge is being lost. When larger companies buy up smaller ones, it’s often with the aim of continuing the individual brands and styles the smaller companies have created. For example, TransCanna has announced the acquisition of GoodFellas, which will allow it to take control of the Daily Cannabis Goods brand. TransCanna CEO Jim Pakulis has talked not in terms of absorbing the Daily brand into TransCanna’s existing identity but in terms of maintaining Daily and expanding its sales.
The consolidation of multiple brands and businesses into a smaller number reflects a dialectic process that’s common in new business areas. First comes a burst of creativity. With few precedents and no big players dominating the market, entrepreneurs and creatives have free rein. Some of their experiments fail, but the ones that succeed get consumers interested and fill the market with ideas.
While this creates plenty of exciting idea and products, it’s also inefficient. In the phase that follows, bigger companies step in or emerge from among the smaller ones. Consolidation creates efficiency, providing more reliable products for consumers and better value for companies.
The contrasting approaches of small innovative companies and larger efficient ones together create excellent value. That’s the point the cannabis industry is now approaching and that TranCanna’s acquisitions are a part of.
The Power of the Immaterial
In the illegal market, all that mattered for cannabis sellers was the product. But in the legal market, things work differently. When a company can use the full apparatus of marketing, intangible assets such as intellectual property become important. That’s why GoodFellas is valuable to a company such as TransCanna — not just for its cannabis but for the Daily brand that’s attached to it.
And while intangible assets are normally talked about in terms of brand and IP, there’s another sort of asset that gets much less publicity and that the cannabis industry is bringing to investors’ attention: legal licenses.
Licenses of various sorts are important for a wide range of industries, from food production to mining. But they have a particular prominence in the cannabis industry because tight regulation has created a scarcity of licenses. When TransCanna subsidiary TCM Distribution Inc. gained cannabis manufacturing and distribution permits from the City of Adelanto, California, it was an important step in the company’s growth within the state. And when a deal like TransCanna’s acquisition of Lyfted is announced, the target’s cannabis licenses are often mentioned. These licenses are a crucial asset and one that investors are concerned about. Without the licenses, the business can’t function.
The prominence of licenses is a new feature of investment for those going into cannabis. But it could be a feature that helps investors recognize these assets in other companies. Cannabis companies are increasingly about immaterial assets, and immaterial assets are increasingly about licenses as well as IP.
Keeping Profiles High
In such an atmosphere, cannabis companies are working hard on keeping their profiles high while building up their portfolios of products.
Canadian cannabis company HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has, like TransCanna, been using acquisitions to build up its business. Originally a medical cannabis provider, HEXO joined the recreational market when Canada changed its laws last year. Since then, it has completed an acquisition of Newstrike, the parent company of Up Cannabis Inc, a licensed producer and distributor. It’s a deal that fits with the importance of immaterial assets. Licensing is important in Canada, both for production and distribution, and acquiring a company that is already licensed is the easiest way to expand a company’s footprint in the country.
Good publicity is another of the intangible assets that come with a good company, and few have achieved more publicity within the sector than Canopy Growth Corporation (TSX: WEED) (NYSE: CGC). When the company received a multibillion-dollar investment from Constellation Brands, it was the first time the sector had received such a big input of cash from outside, so the move drew substantial attention. Now the company is raising its profile in a different way, demonstrating its responsible attitude through the release of digital cannabis education tools.
Aphria Inc. (TSX: APHA) (NYSE: APHA) has taken the hunt for intangible assets global, with the acquisition of five cultivation licenses in Germany. With the North American cannabis industry increasingly well established, Europe is the next big frontier, and Aphria is racing in ahead of many of its competitors.
All this work on intangibles would be useless without physical products to go with it, and product innovation continues at a high pace. Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) has recently announced the release of hemp-extract CBD gummies designed help with calm and sleep. CBD products are an increasingly important subsector of the market, and products of this kind have potentially wide reach.
The cannabis industry is changing, with big money, consolidation and growing intangible assets, but it remains grounded in a strong consumer desire for cannabis.
For more information on TransCanna Holdings, visit TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
MontereyBud
6 years ago
TransCanna Receives Adelanto Adult Use Permits For Manufacturing and Distribution
"Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce the Company’s wholly owned subsidiary, TCM Distribution, Inc., has received an Adult Use Cannabis Manufacturing permit and an Adult Use cannabis distribution permit from the City of Adelanto, California," according to online reports.
"As previously reported on April 18, 2019, TCM Distribution sub-leased 10,000 square feet of warehouse space in Adelanto. Thereafter, TCM Distribution applied for the above two referenced permits with the City of Adelanto which were received on May 28, 2019. TCM Distribution has applied for its state of California Adult Use permanent manufacturing license and distribution licenses, which are pending."
“The purpose of the Adelanto facility is two-fold; first, it’ll be used as one of our southern California satellite facilities for goods being transported from our 196,000 square foot vertically integrated, cannabis focused facility in Modesto. Second, with the non-volatility manufacturing license we’ll be able to accommodate the production and packaging of pre-rolled cannabis products and other products of similar nature, then distribute them accordingly,” stated Jim Pakulis, CEO of TransCanna.
“GoodFellas, one of the entities the Company is preparing to acquire, will be transferring all revenue generating distribution and manufacturing processes to Adelanto once the facility receives its Certificate of Occupancy from the city, and state distribution and manufacturing permits. We anticipate this being completed by the end of June.”
In addition, the TCM Distribution recently purchased and upgraded its state mandated transportation vehicle. The vehicle was purchased in March and received the state required alterations in order to assure state compliance.
In other news, the Company is pleased that the Adelanto city counsel in May approved reducing the tax on transportation, distribution, manufacturing and cannabis testing lab services from 5% down to 1%. The counsel also voted to reduce the cultivation tax from $5 per month per square foot to 42 cents per month per square foot. The dispensaries tax was also reduced from 5% down to 3%.
NetworkNewsWire
6 years ago
Hunt for Perfect Acquisitions Reshapes Cannabis Industry
CannabisNewsWire Editorial Coverage: Cannabis companies are using increasingly refined acquisition tactics to create vertical integration.
TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) has developed a refined acquisition strategy, assessing more than one hundred targets before settling on a select few to acquire. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of America’s leading multistate cannabis companies, has recently announced its agreement to acquire CannaRoyalty Corp. (OTCQX: ORHOF), giving it control over a vast distribution platform. In Canada, HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has been given approval to acquire Newstrike, as the country’s vibrant industry consolidates following recent dramatic growth. For those without vertical integration, companies such as DionyMed Brands Inc. (CSE: DYME) (OTCQB: DYMEF) provide vital support services, including logistics and distribution.
- The cannabis industry is worth tens of billions of dollars and expected to reach more than $146 billion by 2025.
- Legal and social changes mean that companies are working to tap into larger consumer bases.
- Acquisitions create opportunities for integration and efficiency.
To view an infographic of this editorial, click here.
Cannabis Consolidation
The cannabis industry is going through a period of transformation. As more jurisdictions around the world legalize some form of products — whether it’s recreational cannabis, medical cannabis or CBD — the market is seeing explosive growth. Global spending on legal cannabis, which was worth $14.3 billion in 2016, has been predicted to reach $146.4 billion by the end of 2025. This means big profits and big growth for leading cannabis companies, which a decade ago looked like strange novelties to wary investors.
The growth of the industry and in particular some bigger players has led to a period of consolidation. Smaller firms are being swallowed up by their larger competitors as business leaders and investors seek economies of scale, greater brand reach and the higher profits these can bring. From an industry defined by small-scale production and experimentation, cannabis is turning into one of big brands powered by mergers and acquisitions.
Getting Acquisition Right
For those involved in the cannabis industry, it’s easy to get sucked into a gold-rush mind-set. The slightest whiff of marijuana promises fat profits, and every company with a leaf logo looks like a sure thing. But as in any sector, one can find both good and bad options for purchase and investment. For companies set on a strategy of mergers and acquisitions, such as TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8), it’s just as important to be smart as it is to be buying.
Having performed a successful IPO on January 9, 2019, TransCanna is still a relatively new player in the market — but one that appears to be well positioned to make the most of both big markets and industry expertise. Headquartered in Canada, the only G7 country to have nationally legalized recreational cannabis, TransCanna has access to the talent pool and wealth of expertise that Canada has developed. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensure reliability, consistency, quality and scale.
At present, the cannabis industry is in turmoil. Production, branding and distribution are often carried out separately or by small companies, each reaching a fraction of their potential market. TransCanna’s strategy is built around using vertical integration to create a closed-loop cannabis ecosystem, one which more efficiently taps into this exciting market.
To create this integrated system, the company recently purchased a 196,000-square-foot vertically integrated, cannabis-focused facility, which recently went through an $8-million renovation. In addition, the acquisition included five additional acres adjacent to the facility. Once required licenses are in place and the facility is operational, TransCanna will have the following divisions: nursery, cultivation, manufacturing, bottling, extraction and distribution. The facility is also designed to allow up to 10,000 square feet for a third-party, laboratory-testing company to lease space.
Strict Vetting
Over the past 18 months, TransCanna has evaluated more than 100 Californian companies with an eye to acquisition. Strict vetting has whittled these options down to a handful of qualified deals, which TransCanna’s leadership team is pursuing. The company’s evaluation process is deliberate and selective, with an eye to ensuring that every addition plays an essential part in TransCanna’s long-term strategy.
It appears the company’s extreme due diligence on each potential transaction is paying off. In the past 30 days, TransCanna has announced two significant acquisition targets with signed LOIs: Lyfted Farms and SolDaze. It is reasonable to assume more acquisitions are in the works that, conditional upon closing, could certainly bring top-line revenue into the company before year end.
Quality Control
One of these recent acquisitions is also indicative of what makes for a good addition to a cannabis company in the current climate. Lyfted Farms, based in Modesto, California, is another indoor cannabis producer. The company’s three state licenses allow the production and distribution of cannabis from its facility. TransCanna has signed a letter of intent to acquire the company’s business and assets, adding them to its existing operations.
“The proposed acquisition includes an exceptional brand, with a range of high-end flower, growing revenues, fifty exotic and unique genetic strains and a team that’s been a staple in the Modesto valley with over two decades of cultivating experience,” said TransCanna CEO Jim Pakulis. “In short, this is another example of an ideal acquisition candidate for TransCanna that offers SKU velocity, growing revenues and branded products that differentiate from others in the marketplace.”
That focus on quality plant strains is important for TransCanna. Cannabis consumers value quality in their products, and the legalization of the market makes it easier to measure and control this. While the feeding and facilities in which it is cultivated will affect a plant’s outcome, good breeding stock is the fundamental element that will determine its quality. With a variety of great strains in its arsenal, TransCanna will be better placed to expand its vertically integrated cannabis business.
Expansion Across the Cannabis Sector
Another company with a vertically integrated approach to cannabis, Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is one of the leading multistate cannabis companies in the United States, a country where federal laws make it difficult to operate across state boundaries. The company covers the whole value stream of cannabis, from cultivation through processing, packaging and shipping, to sales in dispensaries across the country, some of them owned by Cresco itself. Thanks to its worker-friendly approach, the company has been earning positive publicity for the cannabis sector and was recently singled out as one of the best workplaces in Chicago for employees.
To expand its interstate operations, Cresco recently announced its agreement to acquire CannaRoyalty Corp. (OTCQX: ORHOF), which does business as Origin House. A leading distributor and provider of support services for cannabis companies in California, Origin House will provide Cresco with a vast distribution platform, giving it greater reach across California and expertise and experience in distribution. Origin House adds to the company’s ability to retain control of its business from growing facilities all the way to customers’ hands.
Across the border in Canada, HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has also been pursuing an acquisition strategy. Having entered the cannabis market as a medical provider, the company has added the recreational market to its work, thanks to Canada’s groundbreaking national legislation last year. HEXO announced earlier this year that it will be acquiring Newstrike, the parent company of Up Cannabis Inc., a licensed producer and distributor of cannabis. With the acquisition having received regulatory approval, the companies are set to bring their business together, expanding HEXO’s already impressive work.
For cultivators without TransCanna and Cresco’s level of integration, companies such as DionyMed Brands Inc. (CSE: DYME) (OTCQB: DYMEF) provide essential support services. DionyMed provides value-added services such as logistics, software, packaging and distribution. Rather than acquiring other companies, DionyMed is adding to its value by striking deals with them. The company has recently signed a multimillion-dollar with Blue Kudu, giving DionyMed an exclusive multistate position as distributor for Blue Kudu’s award-winning edibles.
Deals with other cannabis companies can help producers and distributors expand. But acquisitions seem to be the key to real integration and are likely to create cannabis’s future powerhouses.
For more information on TransCanna Holdings, visit TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
6 years ago
Full-Spectrum Seed-to-Sale Model, Quality Branding Key to Cannabis Success
CannabisNewsWire Editorial Coverage: Last year was a year of maturation for the cannabis market.
- California’s growing pains are a recipe for success for handful of savvy operators
- Brands, consistency and scalability likely deciding factors for many companies
- Projected global market size an open-and-shut case for scaling up NA sector
The market growth resulted from retailers in nine legal adult-use states being pushed beyond the sector’s historically core demographics, targeting fast-growing new segments such as women, with an emphasis on elements such as wellness and clearly labeled/low-dose alternatives. That trend was reinforced with CBD breaking out into the mainstream, as industrial hemp became legal throughout the United States, and cannabis companies looked for ways to stand out from the crowd. Some companies were more successful at this than others, with TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) making huge strides recently to expand the upper-end procurement part of the business, as well as flesh-out its footprint of branded offerings. Other moves have been made by comparable sector players such as Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), DionyMed Brands Inc. (OTCQB: DYMEF) (CSE: DYME), Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. (OTCQX: ORHOF) (CSE: OH), which are pursuing similarly comprehensive approaches to the sector that run the gamut from raw inputs to changing branding, marketing and distribution methods.
To view an infographic of this editorial, click here.
Diverse Markets Hold Big Potential
California’s administrative and tax regime may have cost the state half a billion dollars or more in potential cannabis market tax revenues through over regulation, with the state being the first market in the world since transitioning in 2016 from medical to recreational that has actually witnessed a subsequent decline in the size of the legal retail market. This is in stark contrast to Massachusetts and Nevada, which both dramatically outperformed expectations. And while the California legal retail market may have come in around half a billion shy of projected targets, the illicit market is doing just fine, with an estimated value of $3.7 billion last year, accounting for as much as 80% of all sales. This is a clear indicator that the potential exists to have hit analyst-projected targets for the legal market, had California regulators not handicapped a growing industry just as things were really getting started.
In fact, with thousands of cultivation and manufacturing licenses set to expire in the next few months and only Senate Bill 67 on the horizon to address the problem, some analysts are predicting that California may see supply shortages in the near future. At any rate, the national and international markets are shaping up quite nicely, with the most recent worldwide consumer spending estimates from Arcview Market Research and BDS Analytics showing a 39.1% year-over-year jump to $17 billion in 2019 and beyond. This is a market which is on track to run at an estimated 26% CAGR through 2022, hitting upwards of $31.6 billion, making it an extremely lucrative export market for sophisticated North American cannabis brands.
Self-Contained Ecosystem and Closed-Loop Brands
Founded in 2017 with the goal of genuine seed-to-sale capability and rapidly acquiring a bevy of premium cannabis brands, Vancouver-based TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) is pursuing a true “self-contained ecosystem” approach to the sector via its California-based, wholly owned subsidiaries. TransCanna is intent on ensuring maximum brand consistency by handling every aspect of the production process — from procurement and branding and design through to distribution, transportation, marketing and sales.
The company’s latest acquisition announcement will see TransCanna picking up such well-performing Goodfellas Group LLC brands as Daily Cannabis Goods, which saw more than 2,100 units shipped during its first month in August of last year before breaking the 10,000 mark just four months later. TransCanna anticipates adding at least three more items to the Daily Cannabis Goods product mix and also managed to pick up the proprietary, in-house Simple brand of user-friendly Simple Kit™ products in the Goodfellas Group deal, which are specially crafted to give new users a positive first cannabis experience.
Forged in the Crucible of a Nascent Industry
The company cut its teeth amid the growing pains of California’s burgeoning — but still very young — recreational market. Today TransCanna appears well poised to successfully deliver on a closed-loop cannabis model that can cost effectively bring goods to market while still dealing with prevailing regulations.
CEO TransCanna Jim Pakulis spoke in mid-April of the company’s tremendous efforts to complete the acquisition of what is arguably the largest vertically-integrated cannabis focused facility in California. The $15 million acquisition consists of a 196,000-square-foot, turnkey manufacturing facility on a 5.5-acre piece of land in Modesto, estimated to be able to support expansion of the site with an additional 400,000 to 600,000 square feet of facilities for cultivation.
Total revenues from the acquisition, including manufacturing, extraction, distribution and cannabis sales, are currently projected to be from $220 million to $363 million a year. A recent independent third-party business valuation firm’s conclusion put the enterprise value of the proposed business, at around $50 to $75 million. That estimate includes things such as the value of the recently renovated manufacturing facility’s institutional-grade packaging and extraction equipment. This appears to be a sweetheart deal, placing the company in a solid position to take advantage of a potential supply shortfall in California. Similarly, the move sets up TransCanna for success on the rapidly developing national and international stages.
Growth Financing Gone Well
In addition, the company originally announced a CD$10 million broker-syndicated private placement but within short order was oversubscribed to CD$16 million. The funds were used to assist in the aforementioned acquisition and has already executed a sublease agreement for an additional 10,000 square feet of multipurpose floorspace in Adelanto, California.
This satellite facility is the first of five anticipated satellite distribution network facilities that will be strategically located throughout the state to support TransCanna’s goal of quickly having 15 reliable, consistent, branded products on offer at the scale necessary to keep the business growing alongside demand. The completely fenced Adelanto complex is reportedly of superior quality and already has existing round-the-clock armed security, making it a solid deal at a negotiated price of $2 per square foot per month for four years, which is roughly 30% below current market rates.
Furthermore, TransCanna recently applied for a permanent manufacturing, distribution and transportation license for Adelanto, proving that the company’s immediate focus is on ensuring city and state licenses are in hand as soon as possible. The company anticipates applying for licenses with the local regulatory body in Modesto by the first of June. The company anticipates being able to prepare and package the Daily Cannabis Brand half gram pre-rolls at the facility, then transport them straight to dispensaries without the need to involve a third party or incur any additional expenses.
Cannabis Companies Making Big Moves
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), one of the largest players in the space, has made big moves lately to expand its footprint in both North American and Europe. In April, Canopy announced a definitive agreement to acquire leading multistate operator Acreage Holdings Inc. outright in a deal valued at around $3.4 billion. This massive deal could make Canopy a real juggernaut, with a leading position in every major international market for legal cannabis. The move will give the company a sizeable presence in the United States as Canopy rolls out its U.S. hemp operations in parallel, which will span cultivation, extraction, processing, and packaging.
DionyMed Brands Inc. (OTCQB: DYMEF) (CSE: DYME), while still a relatively small company compared to others in this area, has nevertheless put together a compelling model. The company’s approach spans multistate cannabis brands as well as a distribution and direct-to-consumer delivery platform. The company recently managed to secure a roughly $7.34 million agreement with a syndicate of agents co-led by Canaccord Genuity Corp. and leading Canadian independent investment dealer Cormark Securities.
Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) has also been making big moves in the sector, recently prequalifying for a cultivation and processing license in Michigan and signing a letter to acquire VidaCann, one of the biggest and most advanced medical cannabis providers in Florida. The VidaCann deal would put Cresco in operation in six of the country’s most populous states, granting access to some 140 million potential customers (roughly 65 percent of the total addressable U.S. cannabis market).
Cresco also signed a definitive agreement in April to acquire California-based CannaRoyalty Corp. (OTCQX: ORHOF) (CSE: OH), which does business under the well-known Origin House moniker as a leading cannabis products distributor, as well as a provider of brand support services. CannaRoyalty has built a serious operation with more than 50 brands under the Origin House name. The Cresco Labs acquisition would harness the branded product development and distribution expertise of two of the industry’s top players.
TransCanna is banking on the future of intelligently executed cannabis brand offerings, not just in California and North America but around the world as well. With longer-term projections of $57 billion by 2027 for the global market, the company could be setting the cornerstones today of a self-contained ecosystem weed empire that may one day see its premium brands in dispensaries all over the globe. Investors may want to keep tabs on TransCanna as the company’s growing brand portfolio and physical presence in California begin to bear fruits.
For more information on TransCanna Holdings, visit TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ask ADVFN Intelligence (AI)
happyglass
4 years ago
Hot Features
Premium
